Home › Trial NCT06223841
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
- Trial IDNCT06223841
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorSUNHO（China）BioPharmaceutical CO., Ltd.
- Enrollment50
- Start date2024-03-01
- ConditionsAdvanced Malignant Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.